HKG:0399

2 stories mentioning HKG:0399Updated 51d ago

Every FINWIRES story that references HKG:0399, newest first.

Extrawell Pharmaceutical Expects Swing to Loss in Fiscal 2026

Extrawell Pharmaceutical (HKG:0858) expects to post a loss of at least HK$950 million for fiscal 2026, compared with a profit in fiscal 2025, according to a Tuesday Hong Kong bourse filing.The company attributed the expected swing to an unrealized loss on its investment in convertible bonds issued by Starcoin Group (HKG:0399), whose shares were suspended from trading in May, as well as impairment provisions on its interest in an associate and related loan receivables.

HKG:0399HKG:0858

Asia106d ago

Starcoin Seeks Judicial Review After Suspension Decision Upheld

Starcoin Group (HKG:0399) obtained an interim injunction against a decision to suspend trading in its shares and will apply for a judicial review, according to a Wednesday Hong Kong bourse filing.The listing review committee upheld the suspension decision on the grounds that the company failed to maintain a sufficient level of operations under listing rules, the filing showed.The listing review committee cited limited progress in the company's core oral insulin product and noted that its other businesses lack scale, track record, or proven revenue-generating capability, the filing showed.It also noted the company's financial position, including HK$1.1 billion in total assets, mostly intangible assets, and HK$1.1 billion in net current liabilities, as well as reliance on a substantial shareholder for funding.

HKG:0399

Track with the FINWIRES app suite

FolioX

Track HKG:0399 in your portfolio

WheelAI

Analyze HKG:0399 options with the wheel strategy

StockInsider

See market sentiment on HKG:0399